Endocrine gland-derived endothelial growth factor (EG-VEGF) is a potential novel regulator of human parturition

Biology of Reproduction

Volumn 91, Issue 3, 2014, Pages

  Dunand, C ^a,b,c   Hoffmann, P ^a,b,c   Sapin, V ^f   Blanchon, L ^f   Salomon, A ^a,d   Sergent, F ^a,d   Benharouga, M ^c,d,e   Sabra, S ^g   Guibourdenche, J ^h   Lye, S J ^g   Feige, J J ^a,c,d   Alfaidy, N ^a,c,d  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIV GRENOBLE ALPES   (France)

^d CEA GRENOBLE   (France)

^e CNRS   (France)

^f UNIVERSITÉ CLERMONT AUVERGNE   (France)

^g MOUNT SINAI HOSPITAL   (Canada)

^h Institut Cochin   (France)

Author keywords

EG VEGF; Fetal membranes; Human pregnancy; mechanism of parturition; Preterm birth; Trophoblast

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYTOKERATIN 7; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PROKINETICIN RECEPTOR 1; PROKINETICIN RECEPTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; PROKR1 PROTEIN, HUMAN; PROKR2 PROTEIN, HUMAN; RECEPTOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AMNION; ARTICLE; BIRTH CONTROL; CHORION; CHORION CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; EXPLANT; FEMALE; FETUS MEMBRANE; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABOR; LABOR ONSET; PLACENTA; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; BLOOD; CELL CULTURE; CESAREAN SECTION; CYTOLOGY; DOWN REGULATION; METABOLISM; PREGNANCY; REPRODUCTION; SECOND TRIMESTER PREGNANCY; TISSUE CULTURE TECHNIQUE; UPREGULATION;

MUS;

ADULT; AMNION; CELLS, CULTURED; CESAREAN SECTION; CHORION; DOWN-REGULATION; FEMALE; HUMANS; LABOR, OBSTETRIC; PLACENTA; PLACENTATION; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TISSUE CULTURE TECHNIQUES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929512266     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.119990     Document Type: Article

References (34)

1. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001; 412:877-884.
2. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 2001; 59:692-698.
3. Brouillet S, Hoffmann P, Feige JJ, Alfaidy N. EG-VEGF: a key endocrine factor in placental development. Trends Endocrinol Metab 2012; 23:501-508.
4. Evans J, Catalano RD, Brown P, Sherwin R, Critchley HO, Fazleabas AT, Jabbour HN. Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor. FASEB J 2009; 23:2165-2175.
5. Evans J, Catalano RD, Morgan K, Critchley HO, Millar RP, Jabbour HN. Prokineticin 1 signaling and gene regulation in early human pregnancy. Endocrinology 2008; 149:2877-2887.
6. Hoffmann P, Feige JJ, Alfaidy N. Expression and oxygen regulation of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 and its receptors in human placenta during early pregnancy. Endocrinology 2006; 147:1675-1684.
7. Hoffmann P, Feige JJ, Alfaidy N. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation. Placenta 2007; 28:1049-1058.
8. Maldonado-Perez D, Evans J, Denison F, Millar RP, Jabbour HN. Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 2007; 18:66-72.
9. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J Biol Chem 2002; 277:19276-19280.
10. Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ, Alfaidy N. Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 2009; 13:2224-2235.
11. Brouillet S, Murthi P, Hoffmann P, Salomon A, Sergent F, De Mazancourt P, Dakouane-Giudicelli M, Dieudonne MN, Rozenberg P, Vaiman D, Barbaux S, Benharouga M, et al. EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). Cell Mol Life Sci 2013; 70:511-525.
12. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21:514-550.
13. Lannagan TR, Wilson MR, Denison F, Norman JE, Catalano RD, Jabbour HN. Prokineticin 1 induces a pro-inflammatory response in murine fetal membranes but does not induce preterm delivery. Reproduction 2013; 146:581-591.
14. McLaren J, Taylor DJ, Bell SC. Increased concentration of pro-matrix metalloproteinase 9 in term fetal membranes overlying the cervix before labor: implications for membrane remodeling and rupture. Am J Obstet Gynecol 2000; 182:409-416.
15. Vadillo-Ortega F, Gonzalez-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF III. 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995; 146:148-156.
16. Pomini F, Patel FA, Mancuso S, Challis JR. Activity and expression of 15-hydroxyprostaglandin dehydrogenase in cultured chorionic trophoblast and villous trophoblast cells and in chorionic explants at term with and without spontaneous labor. Am J Obstet Gynecol 2000; 182:221-226.
17. Challis JR, Patel FA, Pomini F. Prostaglandin dehydrogenase and the initiation of labor. J Perinat Med 1999; 27:26-34.
18. Patel FA, Challis JR. Cortisol/progesterone antagonism in regulation of 15-hydroxysteroid dehydrogenase activity and mRNA levels in human chorion and placental trophoblast cells at term. J Clin Endocrinol Metab 2002; 87:700-708.
19. Challis JR, Lye SJ, Gibb W. Prostaglandins and parturition. Ann N Y Acad Sci 1997; 828:254-267.
20. Alfaidy N, Li W, MacIntosh T, Yang K, Challis J. Late gestation increase in 11beta-hydroxysteroid dehydrogenase 1 expression in human fetal membranes: a novel intrauterine source of cortisol. J Clin Endocrinol Metab 2003; 88:5033-5038.
21. Alfaidy N, Xiong ZG, Myatt L, Lye SJ, MacDonald JF, Challis JR. Prostaglandin F2alpha potentiates cortisol production by stimulating 11beta-hydroxysteroid dehydrogenase 1: a novel feedback loop that may contribute to human labor. J Clin Endocrinol Metab 2001; 86:5585-5592.
22. Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF III. Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986; 118:1567-1582.
23. Xu P, Alfaidy N, Challis JR. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 2002; 87:1353-1361.
24. Challis JR, Lye SJ, Gibb W, Whittle W, Patel F, Alfaidy N. Understanding preterm labor. Ann N Y Acad Sci 2001; 943:225-234.
25. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350:672-683.
26. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179:1539-1544.
27. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12:642-649.
28. Crispi F, Llurba E, Dominguez C, Martin-Gallan P, Cabero L, Gratacos E. Predictive value of angiogenic factors and uterine artery Doppler for early-versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 31:303-309.
29. Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation. Ultrasound Obstet Gynecol 2008; 32:871-876.
30. Signore C, Mills JL, Qian C, Yu K, Lam C, Epstein FH, Karumanchi SA, Levine RJ. Circulating angiogenic factors and placental abruption. Obstet Gynecol 2006; 108:338-344.
31. Espinoza J, Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Nien JK, Kusanovic JP, Erez O, Bujold E, Goncalves LF, Gomez R, Edwin S. Unexplained fetal death: another anti-angiogenic state. J Matern Fetal Neonatal Med 2007; 20:495-507.
32. Jones CJ, Jauniaux E. Ultrastructure of the materno-embryonic interface in the first trimester of pregnancy. Micron 1995; 26:145-173.
33. Rizek RM, Watson CS, Keating S, Tai HH, Challis JR, Bocking AD. 15-Hydroxyprostaglandin dehydrogenase protein expression in human fetal membranes with and without subclinical inflammation. Reprod Sci 2007; 14:260-269.
34. Pomini F, Caruso A, Challis JR. Interleukin-10 modifies the effects of interleukin-1beta and tumor necrosis factor-alpha on the activity and expression of prostaglandin H synthase-2 and the NAD+-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J Clin Endocrinol Metab 1999; 84:4645-4651.